US OptionsDetailed Quotes
CYTK241115C75000
- 0.40
- -0.20-33.33%
15min DelayClose Oct 25 16:00 ET
0.40High0.40Low
0.40Open0.60Pre Close1 Volume606 Open Interest75.00Strike Price40.00Turnover108.64%IV46.92%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.40Extrinsic Value100Contract SizeAmericanOptions Type0.0777Delta0.0116Gamma128.30Leverage Ratio-0.0488Theta0.0018Rho9.97Eff Leverage0.0168Vega
Cytokinetics Stock Discussion
Sign in to post a comment
Top 5 Upgrades:
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...
12
2
$Cytokinetics (CYTK.US)$ cmonnn I know u can up alot further! 🚀
$Cytokinetics (CYTK.US)$ will there be potential to gain back 100 after the offering?
$Cytokinetics (CYTK.US)$ why drop
2
$SPDR S&P Biotech ETF (XBI.US)$
$Merck & Co (MRK.US)$ x $Immunovant (IMVT.US)$
$Eli Lilly and Co (LLY.US)$ x $Cytokinetics (CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals (REGN.US)$ x $Apellis Pharmaceuticals (APLS.US)$ (panache & brash)
$Gilead Sciences (GILD.US)$ x % $Madrigal Pharmaceuticals (MDGL.US)$ (liver king)
$Bristol-Myers Squibb (BMY.US)$ x $Iovance Biotherapeutics (IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co (LLY.US)$ x $Merus (MRUS.US)$ (partner n...
$Merck & Co (MRK.US)$ x $Immunovant (IMVT.US)$
$Eli Lilly and Co (LLY.US)$ x $Cytokinetics (CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals (REGN.US)$ x $Apellis Pharmaceuticals (APLS.US)$ (panache & brash)
$Gilead Sciences (GILD.US)$ x % $Madrigal Pharmaceuticals (MDGL.US)$ (liver king)
$Bristol-Myers Squibb (BMY.US)$ x $Iovance Biotherapeutics (IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co (LLY.US)$ x $Merus (MRUS.US)$ (partner n...
4
CEO's belief in the company's potential to grow independently may have led to a 3% stock dip. Speculation around a Novartis takeover, and its withdrawal, could have swayed investor sentiment.
1
I'm going to try something new. I'm going to make a Sunday post so that it can be read before the market opens. I hope to still do my update before the market opens on Monday, I always want to see how futures move overnight.
This new thing I'm trying will be some random thoughts about the market. How to use some features on moomoo (a request by some) to do research and develop trading levels. To show this I will introduce some stocks iam in or will be starting positions in.
...
This new thing I'm trying will be some random thoughts about the market. How to use some features on moomoo (a request by some) to do research and develop trading levels. To show this I will introduce some stocks iam in or will be starting positions in.
...
+36
55
18
Truist analyst Srikripa Devarakonda views the recent weakness in Cytokinetics' stock as a buying opportunity and maintains a buy rating and $86 price target on the stock. Devarakonda continues to see Cytokinetics as a potential M&A target.
$SPDR S&P Biotech ETF (XBI.US)$ Jefferies' Yee had a nice report out capturing key JPM comments from large Pharma re: M&A interests. (Summary slide below)
Many thinking $Merck & Co (MRK.US)$ for $Cytokinetics (CYTK.US)$ based on their $15B comment, but $AstraZeneca (AZN.US)$ $Novo-Nordisk A/S (NVO.US)$ mentioned cardiovascular...
Many thinking $Merck & Co (MRK.US)$ for $Cytokinetics (CYTK.US)$ based on their $15B comment, but $AstraZeneca (AZN.US)$ $Novo-Nordisk A/S (NVO.US)$ mentioned cardiovascular...
2
No comment yet
章允量 :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
103677010 : noted